Grant: Alliance Grants
Université du Québec à Trois-Rivières
$50,000.00
Preparation and evaluation of the biological activity of antiviral agents based on copper and silver oxides used in personal protective equipment against SARS-CoV-2 (COVID-19)_x000d_ _x000d_ _x000d_
EF 2020-21
Résumé
NanoBrand Inc. manufactures new nanomaterials as a cost-effective alternative to traditional antibacterial with a great commercialization potential providing solutions in the fight against microorganisms, spores and viruses including newly discovered Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). They already have licenses from Health Canada for wound care, skincare, surface treatment and veterinary disease treatment. Tekna Inc. is a well-known major supplier of copper nanoparticles and alloys in Canada for various applications including antiviral materials. They have used inductively coupled plasma (ICP) technology to produce a wide variety of nanoparticles with well-controlled morphology and properties (sizes and purity) to meet different field related requirements including those for various medical fields and targeted cancer treatments. These two companies wished to develop new nanomaterials by green technology which can be used as efficient antiviral materials against enveloped viruses including SARS-CoV-19. In the context of COVID-19 pandemic, a multidiscipline research team composed of chemists, polymer scientists, biologists (IRSST, UQTR, and UQAC), specialists in nanoparticles-based antibacterial and antiviral agents (NanoBrand Inc., Tekna Inc.) and innovative textile engineers (Innofibre in Trois-Rivières, CTT Group in Saint-Hyacinthe) proposes a project regarding the preparation and rapid evaluation of the biological activity of antimicrobial agents based on nanotechnology to treat cotton and cotton/polyester surfaces used for PPE (masks, medical suits, etc.) against SARS-CoV-2. This project will be carried out to offer antibacterial and antiviral solutions that can be transferred to an application for workplaces in the fight against short-term biological risks.
_x000d_NanoBrand Inc. fabrique de nouveaux nanomatériaux comme une alternative rentable aux antibactériens traditionnels avec un grand potentiel de commercialisation fournissant des solutions dans la lutte contre les micro-organismes, les spores et les virus, y
Programme
Alliance Grants
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
555359-2020
Name nom
Nguyen-Tri, Phuong
Department département
Chimie, biochimie et physique
Organization id
59
Institution établissement
Université du Québec à Trois-Rivières
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
50000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
502
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Fibres and textiles
Area of application fr
Fibres et textiles
Research subject code
3753
Research subject group en
Polymer chemistry
Research subject group fr
Chimie des polymères
Research subject en
Properties of polymers
Research subject fr
Propriétés des polymères
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Preparation and evaluation of the biological activity of antiviral agents based on copper and silver oxides used in personal protective equipment against SARS-CoV-2 (COVID-19)_x000d_
_x000d_
_x000d_
Keyword
NSERC
Application summary
NanoBrand Inc. manufactures new nanomaterials as a cost-effective alternative to traditional antibacterial with a great commercialization potential providing solutions in the fight against microorganisms, spores and viruses including newly discovered Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). They already have licenses from Health Canada for wound care, skincare, surface treatment and veterinary disease treatment. Tekna Inc. is a well-known major supplier of copper nanoparticles and alloys in Canada for various applications including antiviral materials. They have used inductively coupled plasma (ICP) technology to produce a wide variety of nanoparticles with well-controlled morphology and properties (sizes and purity) to meet different field related requirements including those for various medical fields and targeted cancer treatments. These two companies wished to develop new nanomaterials by green technology which can be used as efficient antiviral materials against enveloped viruses including SARS-CoV-19. In the context of COVID-19 pandemic, a multidiscipline research team composed of chemists, polymer scientists, biologists (IRSST, UQTR, and UQAC), specialists in nanoparticles-based antibacterial and antiviral agents (NanoBrand Inc., Tekna Inc.) and innovative textile engineers (Innofibre in Trois-Rivières, CTT Group in Saint-Hyacinthe) proposes a project regarding the preparation and rapid evaluation of the biological activity of antimicrobial agents based on nanotechnology to treat cotton and cotton/polyester surfaces used for PPE (masks, medical suits, etc.) against SARS-CoV-2. This project will be carried out to offer antibacterial and antiviral solutions that can be transferred to an application for workplaces in the fight against short-term biological risks.
_x000d_NanoBrand Inc. fabrique de nouveaux nanomatériaux comme une alternative rentable aux antibactériens traditionnels avec un grand potentiel de commercialisation fournissant des solutions dans la lutte contre les micro-organismes, les spores et les virus, y
